GEN:NYE-Genesis Healthcare Inc. (USD)

EQUITY | Software - Infrastructure | New York Stock Exchange

Last Closing

USD 28.06

Change

-0.11 (-0.39)%

Market Cap

USD 0.52B

Volume

4.55M
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Genesis Healthcare Inc is a post-acute care provider. The Company operates skilled nursing centers and assisted/senior living communities. The Company also supplies rehabilitation and respiratory therapy.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-28 )

Largest Industry Peers for Software - Infrastructure

Symbol Name Price(Change) Market Cap
MSFT Microsoft Corporation

+3.81 (+0.82%)

USD 3,421.64B
PANW Palo Alto Networks Inc

+3.04 (+1.57%)

USD 124.52B
CRWD Crowdstrike Holdings Inc

+2.38 (+0.52%)

USD 109.41B
FTNT Fortinet Inc

+1.88 (+1.85%)

USD 74.91B
SNPS Synopsys Inc

+9.01 (+1.90%)

USD 74.67B
ZS Zscaler Inc

+4.03 (+1.36%)

USD 38.91B
VRSN VeriSign Inc

+3.40 (+1.24%)

USD 26.42B
CHKP Check Point Software Technolog..

+0.20 (+0.09%)

USD 23.91B
OKTA Okta Inc

-1.42 (-1.34%)

USD 22.29B
NTNX Nutanix Inc

+1.20 (+1.56%)

USD 20.03B

ETFs Containing GEN

USPY:F Legal & General UCITS ETF.. 5.73 % 0.00 %

-0.04 (-1.08%)

N/A
BUGU:SW Global X Cybersecurity UC.. 5.55 % 0.00 %

-0.11 (-1.08%)

N/A
CYBR:SW 4.85 % 0.00 %

N/A

N/A
ISPY:SW L&G Cyber Security UCITS .. 4.81 % 0.00 %

+0.06 (+-1.08%)

USD 2.54B
BUG:XETRA Global X Cybersecurity UC.. 4.76 % 0.00 %

+0.06 (+-1.08%)

USD 0.02B
BUGG:AU Global X Cybersecurity ET.. 4.75 % 0.00 %

-0.04 (-1.08%)

N/A
BUG:LSE Global X Cybersecurity UC.. 4.73 % 0.00 %

+0.14 (+-1.08%)

USD 0.05B
BUG Global X Cybersecurity ET.. 4.64 % 0.00 %

+0.14 (+-1.08%)

USD 1.08B
FPXE:LSE First Trust IPOX® Europe.. 4.54 % 0.00 %

+11.90 (+-1.08%)

USD 1.04M
CIBR:LSE First Trust Nasdaq Cybers.. 3.88 % 0.00 %

+0.23 (+-1.08%)

USD 1.00B
FCBR:LSE First Trust Nasdaq Cybers.. 3.88 % 0.00 %

+12.50 (+-1.08%)

USD 1.00B
KNGU:CA Brompton U.S. Cash Flow K.. 3.46 % 0.00 %

-0.11 (-1.08%)

CAD 0.01B
LSEQ Harbor ETF Trust 2.14 % 0.00 %

-0.08 (-1.08%)

USD 0.02B
IQSM Iq Candriam ESG U.S. Mid .. 0.86 % 0.00 %

-0.10 (-1.08%)

N/A
FPXI First Trust International.. 0.00 % 0.70 %

+0.15 (+-1.08%)

USD 0.15B
ZLU-U:CA BMO Low Volatility US Equ.. 0.00 % 0.00 %

-0.18 (-1.08%)

N/A
USPY:LSE L&G Cyber Security UCITS .. 0.00 % 0.00 %

+0.27 (+-1.08%)

USD 2.50B
XSDR:LSE Xtrackers MSCI Europe Hea.. 0.00 % 0.00 %

+36.00 (+-1.08%)

USD 0.21B

Market Performance

  Market Performance vs. Industry/Classification (Software - Infrastructure) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.48% 66% D+ 69% C-
Dividend Return 0.46% 60% D- 25% F
Total Return 2.94% 66% D+ 70% C-
Trailing 12 Months  
Capital Gain 14.53% 61% D- 72% C
Dividend Return 1.53% 57% F 34% F
Total Return 16.06% 62% D 72% C
Trailing 5 Years  
Capital Gain 3,162.79% 98% N/A 99% N/A
Dividend Return 290.70% 100% F 100% F
Total Return 3,453.49% 98% N/A 99% N/A
Average Annual (5 Year Horizon)  
Capital Gain 2,159.99% 98% N/A 99% N/A
Dividend Return 2,160.80% 98% N/A 99% N/A
Total Return 0.81% 43% F 21% F
Risk Return Profile  
Volatility (Standard Deviation) 3,791.66% 3% F 2% F
Risk Adjusted Return 56.99% 88% B+ 83% B
Market Capitalization 0.52B N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Software - Infrastructure) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.